Coombes RC, Tovey H, Kilburn L, et al. A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial). SABCS 2017, GS3-03.
Podcast: Progress in PARP inhibitors - An exciting option for treating metastatic prostate cancer?
dec 2023 | Uro-oncologie